| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb2c65fed767c6cdb08ca3b49dbb9f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 |
| filingDate |
2004-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1916dec79e9b461f7ad6c5b65435820
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_881b492c67abbd2fe9dbe3d5331f5423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9a6d04929edd22cd40f04497915d3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec78ab3189e2fa94a838e0aab59be27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0608cd0ab3fcde806abdef2ab8ad67e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ea28fc36baf2b00c810becb9906aa6b |
| publicationDate |
2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005130974-A1 |
| titleOfInvention |
Benzothiazole compositions and their use as ubiquitin ligase inhibitors |
| abstract |
This invention describes compounds and pharmaceutical compositions useful as ubiquitin agent inhibitors. The compounds and pharmaceutical compositions of the invention are useful as inhibitors of the biochemical pathways of organisms in which ubiquitination is involved. The invention also comprises the use of the compounds and pharmaceutical compositions of the invention for the treatment of conditions that require inhibition of ubiquitination. Furthermore, the invention comprises methods of inhibiting ubiquitination in a cell comprising contacting a cell in which inhibition of ubiquitination is desired with a pharmaceutical composition according to the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7098216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017515901-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8202889-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006128717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011091209-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005065116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102391207-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102391207-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011071192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637548-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010331369-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9301953-B2 |
| priorityDate |
2003-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |